Skip to main content

Myrbetriq and Alcohol/Food Interactions

There are 2 alcohol/food/lifestyle interactions with Myrbetriq (mirabegron).


Mirabegron Food

Minor Food Interaction

Information for this minor interaction is available on the professional version.


Mirabegron High Blood Pressure (Hypertension)

Moderate Potential Hazard, Moderate plausibility

mirabegron - hypertension

Mirabegron can increase blood pressure. In clinical studies, the use of mirabegron was associated with dose-related increases in supine blood pressure. At the maximum recommended dose of 50 mg, the mean maximum increase in systolic/diastolic blood pressure was approximately 3.5/1.5 mmHg greater than placebo in healthy volunteers and approximately 0.5 to 1 mmHg greater than placebo in patients with overactive bladder. Worsening of preexisting hypertension was reported infrequently in patients receiving mirabegron. Therapy with mirabegron should be administered cautiously in patients with hypertension. Periodic blood pressure determinations are recommended. Mirabegron is not recommended for use in patients with severe, uncontrolled hypertension, defined as systolic blood pressure >=180 mm Hg and/or diastolic blood pressure >=110 mm Hg.


  1. (2012) "Product Information. Myrbetriq (mirabegron)." Astellas Pharma US, Inc

Myrbetriq drug interactions

There are 234 drug interactions with Myrbetriq (mirabegron).

Myrbetriq disease interactions

There are 4 disease interactions with Myrbetriq (mirabegron) which include:

Report options

QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.